Current trends in the employment of psychotropic medication in somatic illness are considered, and some of the theoretical issues raised by this practice are explored. While much further clinical investigation is needed, a review is made of currently available knowledge regarding psychopharmacotherapy in specific clinical settings: pain, delirium, ischemic heart disease, gastrointestinal disorders, dermatological illness, and in renal, hepatic and pulmonary insufficiency.
Get full access to this article
View all access options for this article.
References
1.
BlackwellB: Psychotropic drugs in use today: The role of diazepam in medical practice. JAMA225:1637–41, 1973
2.
ParryHJBalterMBMellingerGD: National patterns of psychotherapeutic drug use. Arch Gen Psychiat28:769–83, 1973
3.
GoldbergDPBlackwellB: Psychiatric illness in general practice: A detailed study using a method of case identification. Brit Med J2:439–43, 1970
4.
WheatleyD: Evaluation of psychotropic drugs in general practice. Proc Roy Soc Med65:317–20, 1970
5.
HollisterLE: Clinical use of psychotherapeutic drugs. Drugs4:321–410, 1972
6.
GreenblattDJShaderRI: Benzodiazepines in Clinical Practice. New York, Raven Press, 1974
ParrishPA: The prescribing of psychotropic drugs in general practice. J Roy Coll Gen Pract21: SupplementNo 4, Nov, 1971
9.
HusseyHH: Drugs for anxiety. JAMA228:875, 1974
10.
GardnerEA: Implications of psychoactive drug therapy. New Engl J Med290:800–802, 1974
11.
ManheimerDIDavidsonSTBalterMB: Popular attitudes and beliefs about tranquilizers. Amer J Psychiat130:1246–53, 1973
12.
BalterMBLevineJManheimerDI: Cross-national study of the extent of antianxiety/sedative drug use. New Engl J Med290:769–74, 1974
13.
DiMascioAShaderRI: Clinical Handbook of Psychopharmacology. New York, Science House, 1970
14.
TyrerPJ: Relevance of bodily feelings in emotion. Lancet1:915–16, 1973
15.
GundersonEKERaheRH: Life Stress and Illness. Springfield, Charles C Thomas, 1974
16.
Antianxiety drugs in organic and functional syndromes. Med Lett Drugs Ther14:93–94, 1972
17.
TaggartPCarruthersM: Suppression by oxyprenolol of adrenergic response to stress. Lancet2:256–58, 1972
18.
JeffersonJW: Beta-adrenergic receptor blocking drugs in psychiatry. Arch Gen Psychiat31:681–91, 1974
19.
JanisILLeventhalH: Psychological aspects of physical illness and hospital care, in Handbook of Clinical Psychology. Edited by WolmanB. New York, McGraw-Hill, 1965, pp 1360–77
20.
SteinEHMurdaughJMacleodJA: Brief psychotherapy of psychiatric reactions to physical illness. Amer J Psychiat125:1040–1047, 1969
21.
GoldbergIKMalitzSKutscherAH: Psychopharmacological Agents for the Terminally Ill and Bereaved. New York, Columbia University Press, 1973
22.
SchwabJJClemmonsRSBialowMR: A study of the somatic symptomatology of depression in medical inpatients. Psychosomatics6:273–76, 1965
23.
KievA: Somatic Manifestations of Depressive Disorders. Amsterdam, Excerpta Medica, 1974
24.
KielholzP: Masked Depression. Bern, Hans Huber, 1973
25.
SchwabJJBialowMRBrownJMHolzerCE: Diagnosing depression in medical in-patients. Ann Int Med67:695–707, 1967
26.
FawcettJ: Suicidal depression and physical illness. JAMA219:1303–306, 1972
27.
DavisWG: Treating psychical disturbances induced by physical disorders: A double blind study of perphenazine-amitriptyline in anxiety and depression. Psychosomatics9:44–46, 1968
28.
KlineNS: Antidepressant medications: A more effective use by general practitioners, family physicians, internists, and others. JAMA227:1158–160, 1974
29.
ChapmanCRFeatherBW: Effects of diazepam on human pain tolerance and pain sensitivity. Psychosom Med35:330–39, 1973
30.
BeecherHK: Anxiety and pain. JAMA209:1080, 1969
31.
SternbachRA: Pain: A Psychophysiological Analysis. New York, Academic Press, 1968
32.
KlermanGI: Drugs and the dying patient, in Psychopharmalogical Agents for the Terminally Ill and Bereaved. Edited by GoldbergIKMalitzSKutscherAH. New York, Columbia University Press, 1973, pp 15–16
33.
MerskeyHHesterRA: The treatment of chronic pain with psychotropic drugs. Postgrad Med J48:594–98, 1972
34.
SternbachRA: Pain and depression, in Somatic Manifestations of Depressive Disorders. Edited by KievA. Amsterdam, Excerpta Medica, 1974, pp 107–19
35.
EngelGL: Delirium, in Comprehensive Textbook of Psychiatry. Edited by FreedmanAMKaplanHI. Baltimore, Williams & Wilkins, 1967, pp 711–16
36.
HenryDWMannAM: Diagnosis and treatment of delirium. Canad Med Ass J93:1156–166, 1965
37.
BlachlyPHStarrA: Treatment of delirium with phenothiazine drugs following open heart surgery. Dis Nerv Syst27:107–10, 1966
38.
DetreTPJareckiHG: Modern Psychiatric Treatment. Philadelphia, JB Lippincott, 1971, pp 422–23
39.
JohnsonMH: Drugs of choice in confusional states. Med Times100:93–99, 1972
40.
SchwabJJ: Handbook of Psychiatric Consultation. New York, Appleton-Century-Crofts, 1968, pp 176–88
41.
AydFJJr: Haloperidol: Fifteen years of experience. Dis Nerv Syst33:459–69, 1972
42.
GerleB: Clinical observations of the side effects of haloperidol. Acta Psychiat Scand40:65–76, 1964
43.
Are there any reports of organic brain syndrome resulting from the concomitant use of phenothiazines and anti-Parkinsonian agents?N Y State J Med73:2898–99, 1973
44.
HackettTPCassemNHWishnieH: Detection and treatment of anxiety in the coronary care unit. Amer Heart J78:727–30, 1969
45.
CassemNHHackettTP: Psychiatric consultation in a coronary care unit. Ann Int Med75:9–14, 1971
46.
HackettTPCassemNA: Reduction of anxiety in the coronary care unit. A controlled double-blind comparison of chlordiazepoxide and amobarbital. Curr Ther Res14:649–56, 1972
47.
WishnieHAHackettTPCassemNH: Psychological hazards of convalescence following myocardial infarction. JAMA215:1292–96, 1971
48.
WynnA: Unwarranted emotional distress in men with ischemic heart disease (IHD). Med J Aust2:847–51, 1967
49.
EbertMHShaderRI: Cardiovascular effects, in Psychotropic Drug Side Effects. Edited by ShaderRIDiMascioA.Baltimore, Williams & Wilkins, 1970, pp 149–63
50.
Cardiovascular complications from psychotropic drugs. Brit Med J1:3, 1971
51.
CraneGE: Cardiac toxicity and psychotropic drugs. Dis Nerv Syst31:534–39, 1970
52.
RaisfieldIH: Cardiovascular complications of antidepressant therapy. Amer Heart J83:129–33, 1972
53.
Cardiovascular complications of tricyclic antidepressants. New Zeald Med J74:390–91, 1971
54.
MoirDCCornwallWBCrooksJ: Cardiotoxicity of amitriptyline. Lancet2:561–64, 1972
55.
Report from Boston Collaborative Drug Surveillance Program: Adverse reactions to the tricyclic antidepressant drugs. Lancet1:529–31, 1972
56.
Doxepin: A review. Drugs1:194–227, 1971
57.
AydFJ: Long term administration of doxepin (Sinequan). (Clinical and laboratory survey of 40 patients). Dis Nerv Syst32:617–22, 1971
58.
MilnerG: Adverse reactions and the specificity of antidepressant drug effects. Med J Austr2:272–74, 1971
59.
HollisterLE: Diagnosis and treatment: Drugs five years later—Doxepin hydrochloride. Ann Intern Med81:360–63, 1974
60.
PrattIT: Twilight sleep after infarction. Brit Med J3:475–76, 1971
61.
Haloperidol: Med Lett Drugs Ther9:70–71, 1967
62.
SimpsonFO: Hypertension and depression and their treatment. Austr N Z J Psychiat7:1–5, 1973
63.
BantW: Do antihypertensive drugs really cause depression?Proc Roy Soc Med67:919–21, 1974
64.
EbertEHShaderRI: Hepatic effects, in Psychotropic Drug Side Effects. Edited by ShaderRIDiMascioA.Baltimore, Williams & Wilkins, pp 175–97
65.
BirnbaumDKarmeliFTeferaM: The effect of diazepam on human gastric secretion. Gut12:616–18, 1971
66.
BirnbaumDBen-MenachemJSchwartzA: The influence of oral diazepam on gastrointestinal motility: A preliminary report. Amer J Proctol21:263–66, 1970
67.
HockCW: Antidepressant therapy in gastrointestinal conditions: Clinical evaluation of desipramine-hydrochloride (Norpramin). Psychosomatics10:121–24, 1969
68.
OrenBG: Stress related gastrointestinal dysfunction and combined antidepressant-tranquilizer therapy. Psychosomatics10:258–63, 1969
